Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration

Clinical trial NCT00940641 · SUSPENDED

Trial details

NCT number: NCT00940641
Sponsor: AstraZeneca
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Absorption Distribution Metabolism Excretion

Start date: 2009-08-01
Primary completion: 2009-10-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.